{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:38:51Z","timestamp":1794613131388,"version":"4.9.1"},"reference-count":168,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003493","name":"Hertie Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003493","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["TRR274"],"award-info":[{"award-number":["TRR274"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["TRR355"],"award-info":[{"award-number":["TRR355"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["GRK2668"],"award-info":[{"award-number":["GRK2668"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["EXC 2145"],"award-info":[{"award-number":["EXC 2145"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["SFB1054"],"award-info":[{"award-number":["SFB1054"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["490846870"],"award-info":[{"award-number":["490846870"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["435874434"],"award-info":[{"award-number":["435874434"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["408885537"],"award-info":[{"award-number":["408885537"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["210592381"],"award-info":[{"award-number":["210592381"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["390857198"],"award-info":[{"award-number":["390857198"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.smim.2025.101947","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T10:39:12Z","timestamp":1743763152000},"page":"101947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["The role of the adaptive immune system in the initiation and persistence of multiple sclerosis"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3256-5298","authenticated-orcid":false,"given":"Ali Maisam","family":"Afzali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3633-0955","authenticated-orcid":false,"given":"Thomas","family":"Korn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.smim.2025.101947_bib1","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2023.03.008","article-title":"Multiple sclerosis: neuroimmune crosstalk and therapeutic targeting","volume":"186","author":"Charabati","year":"2023","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.smim.2025.101947_bib2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"S. International Advisory Committee on Clinical Trials in Multiple, Multiple sclerosis progression: time for a new mechanism-driven framework, The","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.smim.2025.101947_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41582-022-00624-x","article-title":"The role of glial cells in multiple sclerosis disease progression","volume":"18","author":"Healy","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.smim.2025.101947_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2024.05.025","article-title":"Neurodegeneration and demyelination in multiple sclerosis","author":"Garton","year":"2024","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.smim.2025.101947_bib5","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.it.2024.08.003","article-title":"Disease-associated oligodendroglia: a putative nexus in neurodegeneration","volume":"45","author":"Castelo-Branco","year":"2024","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.smim.2025.101947_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med"},{"issue":"10422","key":"10.1016\/j.smim.2025.101947_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","article-title":"Multiple sclerosis","volume":"403","author":"Jakimovski","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.smim.2025.101947_bib8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1474-4422(14)70305-9","article-title":"Role of the innate and adaptive immune responses in the course of multiple sclerosis","volume":"14","author":"Hemmer","year":"2015","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.smim.2025.101947_bib9","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.tig.2017.09.004","article-title":"The genetics of multiple sclerosis: from 0 to 200 in 50 years","volume":"33","author":"Baranzini","year":"2017","journal-title":"Trends Genet.: TIG"},{"issue":"6460","key":"10.1016\/j.smim.2025.101947_bib10","article-title":"C. International Multiple Sclerosis Genetics, Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility","volume":"365","year":"2019","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.smim.2025.101947_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","article-title":"Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis","volume":"13","author":"Olsson","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.smim.2025.101947_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.smim.2025.101947_bib13","article-title":"Multiple sclerosis: emerging epidemiological trends and redefining the clinical course, The Lancet regional health","volume":"44","author":"Portaccio","year":"2024","journal-title":"Europe"},{"issue":"7744","key":"10.1016\/j.smim.2025.101947_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41586-019-0924-x","article-title":"Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution","volume":"566","author":"Masuda","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.smim.2025.101947_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41593-024-01765-6","article-title":"Spatially resolved gene signatures of white matter lesion progression in multiple sclerosis","author":"Alsema","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.smim.2025.101947_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41593-024-01796-z","article-title":"Cell type mapping reveals tissue niches and interactions in subcortical multiple sclerosis lesions","author":"Lerma-Martin","year":"2024","journal-title":"Nat. Neurosci."},{"issue":"740","key":"10.1016\/j.smim.2025.101947_bib17","doi-asserted-by":"crossref","first-page":"eade8560","DOI":"10.1126\/scitranslmed.ade8560","article-title":"Competence Network Multiple, Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories","volume":"16","author":"Gross","year":"2024","journal-title":"Sci. Transl. Med"},{"issue":"9","key":"10.1016\/j.smim.2025.101947_bib18","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jamaneurol.2020.1568","article-title":"Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials","volume":"77","author":"Kappos","year":"2020","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.smim.2025.101947_bib19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1212\/WNL.49.2.351","article-title":"Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial","volume":"49","author":"Van Oosten","year":"1997","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.smim.2025.101947_bib20","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.4049\/jimmunol.1301926","article-title":"Differential reconstitution of T cell subsets following immunodepleting treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with relapsing-remitting multiple sclerosis","volume":"191","author":"Zhang","year":"2013","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2025.101947_bib21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.410360210","article-title":"Repeated treatment with chimeric anti-CD4 antibody in multiple sclerosis","volume":"36","author":"Lindsey","year":"1994","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.smim.2025.101947_bib22","first-page":"771","article-title":"Treatment of multiple sclerosis with anti-CD4 monoclonal antibody","volume":"6","author":"Racadot","year":"1993","journal-title":"A Prelim. Rep. B-F5 21 Patients, J. Autoimmun."},{"issue":"17","key":"10.1016\/j.smim.2025.101947_bib23","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1056\/NEJMoa0802670","article-title":"Alemtuzumab vs. interferon beta-1a in early multiple sclerosis","volume":"359","author":"Investigators","year":"2008","journal-title":"N. Engl. J. Med"},{"issue":"9856","key":"10.1016\/j.smim.2025.101947_bib24","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(12)61768-1","article-title":"Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial","volume":"380","author":"Coles","year":"2012","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.smim.2025.101947_bib25","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/80516","article-title":"Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand","volume":"6","author":"Bielekova","year":"2000","journal-title":"Nat. Med"},{"issue":"6364","key":"10.1016\/j.smim.2025.101947_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/356063a0","article-title":"Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin","volume":"356","author":"Yednock","year":"1992","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.smim.2025.101947_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJMoa020696","article-title":"G. International Natalizumab Multiple Sclerosis Trial, A controlled trial of natalizumab for relapsing multiple sclerosis","volume":"348","author":"Miller","year":"2003","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.smim.2025.101947_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cell.2018.08.011","article-title":"Memory B cells activate brain-homing, autoreactive CD4(+) T cells in multiple sclerosis","volume":"175","author":"Jelcic","year":"2018","journal-title":"Cell"},{"issue":"7560","key":"10.1016\/j.smim.2025.101947_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.smim.2025.101947_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ni.3666","article-title":"The movers and shapers in immune privilege of the CNS","volume":"18","author":"Engelhardt","year":"2017","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.smim.2025.101947_bib31","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/s41593-022-01108-3","article-title":"Distinct roles of the meningeal layers in CNS autoimmunity","volume":"25","author":"Merlini","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.smim.2025.101947_bib32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nri.2016.144","article-title":"T cell responses in the central nervous system","volume":"17","author":"Korn","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"7269","key":"10.1016\/j.smim.2025.101947_bib33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature08478","article-title":"Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions","volume":"462","author":"Bartholomaus","year":"2009","journal-title":"Nature"},{"issue":"6425","key":"10.1016\/j.smim.2025.101947_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat7554","article-title":"Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation","volume":"363","author":"Jordao","year":"2019","journal-title":"Science"},{"issue":"8044","key":"10.1016\/j.smim.2025.101947_bib35","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41586-024-08279-y","article-title":"Endogenous self-peptides guard immune privilege of the central nervous system","volume":"637","author":"Kim","year":"2025","journal-title":"Nature"},{"issue":"7359","key":"10.1016\/j.smim.2025.101947_bib36","article-title":"A. Compston, Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","author":"International Multiple Sclerosis Genetics","year":"2011","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.smim.2025.101947_bib37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1474-4422(15)00313-0","article-title":"The search for the target antigens of multiple sclerosis, part 2: CD8+\u2009T cells, B cells, and antibodies in the focus of reverse-translational research","volume":"15","author":"Hohlfeld","year":"2016","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.smim.2025.101947_bib38","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1474-4422(15)00334-8","article-title":"The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+\u2009T lymphocytes as pathogenic effectors and therapeutic targets","volume":"15","author":"Hohlfeld","year":"2016","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.smim.2025.101947_bib39","article-title":"T-Cell Specificity Influences Disease Heterogeneity in Multiple Sclerosis","volume":"8","author":"Cruciani","year":"2021","journal-title":"Neurol. (R. ) Neuroimmunol. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.smim.2025.101947_bib40","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.cell.2020.09.054","article-title":"HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis","volume":"183","author":"Wang","year":"2020","journal-title":"Cell"},{"issue":"44","key":"10.1016\/j.smim.2025.101947_bib41","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2416097121","article-title":"CD4 T cells restricted to DRB1*\u200915:01 recognize two Epstein-Barr virus glycoproteins capable of intracellular antigen presentation","volume":"121","author":"Drosu","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.smim.2025.101947_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-024-02938-3","article-title":"An autoantibody signature predictive for multiple sclerosis","author":"Zamecnik","year":"2024","journal-title":"Nat. Med"},{"issue":"11","key":"10.1016\/j.smim.2025.101947_bib43","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1212\/WNL.40.11.1770","article-title":"Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals","volume":"40","author":"Pette","year":"1990","journal-title":"Neurology"},{"issue":"6280","key":"10.1016\/j.smim.2025.101947_bib44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/346183a0","article-title":"T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis","volume":"346","author":"Ota","year":"1990","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.smim.2025.101947_bib45","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4049\/jimmunol.145.2.540","article-title":"Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals","volume":"145","author":"Martin","year":"1990","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2025.101947_bib46","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1172\/JCI119539","article-title":"Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire","volume":"100","author":"Muraro","year":"1997","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.smim.2025.101947_bib47","doi-asserted-by":"crossref","first-page":"1110672","DOI":"10.3389\/fimmu.2023.1110672","article-title":"Characterization of antigen-specific CD8+\u2009memory T cell subsets in peripheral blood of patients with multiple sclerosis","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol."},{"issue":"10","key":"10.1016\/j.smim.2025.101947_bib48","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/s41590-021-01009-w","article-title":"Repositioning T(H) cell polarization from single cytokines to complex help","volume":"22","author":"Tuzlak","year":"2021","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.smim.2025.101947_bib49","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat. Med"},{"key":"10.1016\/j.smim.2025.101947_bib50","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2025.101947_bib51","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/s41467-017-01571-8","article-title":"Transcriptional signature of human pro-inflammatory TH17 cells identifies reduced IL10 gene expression in multiple sclerosis","volume":"8","author":"Hu","year":"2017","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.smim.2025.101947_bib52","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.cell.2015.11.009","article-title":"Single-cell genomics unveils critical regulators of Th17 cell pathogenicity","volume":"163","author":"Gaublomme","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.smim.2025.101947_bib53","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029637","article-title":"The interleukin (IL)-23\/T helper (Th)17 axis in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"8","author":"Hiltensperger","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"10.1016\/j.smim.2025.101947_bib54","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1038\/ncomms4770","article-title":"IL-27 and IL-12 oppose pro-inflammatory IL-23 in CD4+\u2009T cells by inducing Blimp1","volume":"5","author":"Heinemann","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2025.101947_bib55","doi-asserted-by":"crossref","first-page":"11541","DOI":"10.1038\/ncomms11541","article-title":"Experimental priming of encephalitogenic Th1\/Th17 cells requires pertussis toxin-driven IL-1beta production by myeloid cells","volume":"7","author":"Ronchi","year":"2016","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.smim.2025.101947_bib56","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1172\/JCI128475","article-title":"Early adaptive immune activation detected in monozygotic twins with prodromal multiple sclerosis","volume":"129","author":"Beltran","year":"2019","journal-title":"J. Clin. Invest"},{"issue":"8","key":"10.1016\/j.smim.2025.101947_bib57","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s41591-019-0521-4","article-title":"GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosis","volume":"25","author":"Galli","year":"2019","journal-title":"Nat. Med"},{"issue":"4","key":"10.1016\/j.smim.2025.101947_bib58","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-020-00446-2","article-title":"Transcriptional regulation of memory B cell differentiation","volume":"21","author":"Laidlaw","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2025.101947_bib59","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev-immunol-090222-102834","article-title":"T Follicular Helper Cell Heterogeneity","volume":"42","author":"Song","year":"2024","journal-title":"Annu Rev. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2025.101947_bib60","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","article-title":"Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion","volume":"34","author":"Morita","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2025.101947_bib61","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3389\/fimmu.2018.00382","article-title":"Role of TFH cells in promoting T helper 17-induced neuroinflammation","volume":"9","author":"Quinn","year":"2018","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.smim.2025.101947_bib62","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41467-019-14118-w","article-title":"Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis","volume":"11","author":"Schafflick","year":"2020","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.smim.2025.101947_bib63","article-title":"Multiple Sclerosis CSF Is Enriched With Follicular T Cells Displaying a Th1\/Eomes Signature","volume":"9","author":"Morille","year":"2022","journal-title":"Neurol. (R. ) Neuroimmunol. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.smim.2025.101947_bib64","article-title":"Increased intrathecal activity of follicular helper T cells in patients with relapsing-remitting multiple sclerosis","volume":"9","author":"Holm Hansen","year":"2022","journal-title":"Neurol. (R. ) Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.smim.2025.101947_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.110262","article-title":"Effects of anti-CD20 therapy on circulating and intrathecal follicular helper T cell subsets in multiple sclerosis","volume":"264","author":"Mahdaoui","year":"2024","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2025.101947_bib66","article-title":"B cell depletion attenuates CD27 signaling of T helper cells in multiple sclerosis","volume":"5","author":"Ulutekin","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"7","key":"10.1016\/j.smim.2025.101947_bib67","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1177\/1352458518779951","article-title":"Peripheral imbalanced TFH\/TFR ratio correlates with intrathecal IgG synthesis in multiple sclerosis at clinical onset","volume":"25","author":"Puthenparampil","year":"2019","journal-title":"Mult. Scler."},{"key":"10.1016\/j.smim.2025.101947_bib68","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3389\/fimmu.2018.00944","article-title":"T Follicular helper-like cells are involved in the pathogenesis of experimental autoimmune encephalomyelitis","volume":"9","author":"Guo","year":"2018","journal-title":"Front Immunol."},{"issue":"20","key":"10.1016\/j.smim.2025.101947_bib69","doi-asserted-by":"crossref","DOI":"10.1172\/JCI156254","article-title":"Impaired TIGIT expression on B cells drives circulating follicular helper T cell expansion in multiple sclerosis","volume":"132","author":"Asashima","year":"2022","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.smim.2025.101947_bib70","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3389\/fimmu.2018.01097","article-title":"Relapsing-remitting multiple sclerosis is characterized by a T follicular cell pro-inflammatory shift, reverted by dimethyl fumarate treatment","volume":"9","author":"Cunill","year":"2018","journal-title":"Front Immunol."},{"issue":"5","key":"10.1016\/j.smim.2025.101947_bib71","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.4049\/jimmunol.1900955","article-title":"Fingolimod profoundly reduces frequencies and alters subset composition of circulating T follicular helper cells in multiple sclerosis patients","volume":"204","author":"Huber","year":"2020","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2025.101947_bib72","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","article-title":"Human FOXP3(+) regulatory T cell heterogeneity and function in autoimmunity and cancer","volume":"50","author":"Wing","year":"2019","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.smim.2025.101947_bib73","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+\u2009regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.smim.2025.101947_bib74","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1002\/eji.200526065","article-title":"Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis","volume":"35","author":"Haas","year":"2005","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.smim.2025.101947_bib75","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+\u2009regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J. Exp. Med"},{"issue":"2","key":"10.1016\/j.smim.2025.101947_bib76","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ni1428","article-title":"Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice","volume":"8","author":"Kim","year":"2007","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2025.101947_bib77","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00401-013-1159-9","article-title":"Th1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell response","volume":"126","author":"Lowther","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"7090","key":"10.1016\/j.smim.2025.101947_bib78","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.smim.2025.101947_bib79","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1564","article-title":"Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation","volume":"13","author":"Korn","year":"2007","journal-title":"Nat. Med"},{"issue":"2","key":"10.1016\/j.smim.2025.101947_bib80","doi-asserted-by":"crossref","first-page":"958","DOI":"10.4049\/jimmunol.179.2.958","article-title":"The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+\u2009regulatory T cells","volume":"179","author":"O'Connor","year":"2007","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2025.101947_bib81","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nri.2016.26","article-title":"T cell receptor signalling in the control of regulatory T cell differentiation and function","volume":"16","author":"Li","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2025.101947_bib82","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.immuni.2014.10.012","article-title":"Continuous T cell receptor signals maintain a functional regulatory T cell pool","volume":"41","author":"Vahl","year":"2014","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.smim.2025.101947_bib83","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.immuni.2019.12.002","article-title":"Precursors for Nonlymphoid-tissue Treg Cells Reside in Secondary Lymphoid Organs and Are Programmed by the Transcription Factor BATF","volume":"52","author":"Delacher","year":"2020","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.smim.2025.101947_bib84","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.celrep.2019.01.070","article-title":"Blimp1 prevents methylation of Foxp3 and loss of regulatory T cell identity at sites of inflammation","volume":"26","author":"Garg","year":"2019","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.smim.2025.101947_bib85","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41590-022-01208-z","article-title":"Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammation","volume":"23","author":"Yshii","year":"2022","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2025.101947_bib86","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41590-022-01201-6","article-title":"CNS T(reg) cells have alternative functions but run on conventional fuel","volume":"23","author":"Korn","year":"2022","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2025.101947_bib87","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4049\/jimmunol.1402140","article-title":"In vivo maintenance of human regulatory T cells during CD25 blockade","volume":"194","author":"Huss","year":"2015","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.smim.2025.101947_bib88","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1177\/1352458518819098","article-title":"Severe meningo-\/encephalitis after daclizumab therapy for multiple sclerosis","volume":"25","author":"Stork","year":"2019","journal-title":"Mult. Scler."},{"key":"10.1016\/j.smim.2025.101947_bib89","doi-asserted-by":"crossref","unstructured":"T. Korn, Chapter 4 - T cells in multiple sclerosis, in: F.J. Quintana (Ed.), Mechanisms of Disease Pathogenesis in Multiple Sclerosis, Academic Press 2024, pp. 125-150.","DOI":"10.1016\/B978-0-12-823848-6.00004-X"},{"issue":"8","key":"10.1016\/j.smim.2025.101947_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250227","article-title":"Foxp3(+) regulatory T cells in the central nervous system and other nonlymphoid tissues","volume":"53","author":"Korn","year":"2023","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2025.101947_bib91","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1084\/jem.192.3.393","article-title":"Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction","volume":"192","author":"Babbe","year":"2000","journal-title":"J. Exp. Med"},{"issue":"7","key":"10.1016\/j.smim.2025.101947_bib92","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/brain\/awy151","article-title":"The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+\u2009T lymphocytes and B cells","volume":"141","author":"Machado-Santos","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.smim.2025.101947_bib93","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu Rev. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2025.101947_bib94","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/brain\/awaa117","article-title":"Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions","volume":"143","author":"Fransen","year":"2020","journal-title":"Brain"},{"issue":"42","key":"10.1016\/j.smim.2025.101947_bib95","doi-asserted-by":"crossref","first-page":"17872","DOI":"10.1073\/pnas.1010201107","article-title":"Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence","volume":"107","author":"Wakim","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.smim.2025.101947_bib96","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00401-017-1744-4","article-title":"Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients","volume":"134","author":"van Nierop","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1016\/j.smim.2025.101947_bib97","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","article-title":"Dysregulated epstein-barr virus infection in the multiple sclerosis brain","volume":"204","author":"Serafini","year":"2007","journal-title":"J. Exp. Med"},{"issue":"11","key":"10.1016\/j.smim.2025.101947_bib98","article-title":"Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosis","volume":"219","author":"Schneider-Hohendorf","year":"2022","journal-title":"J. Exp. Med"},{"issue":"498","key":"10.1016\/j.smim.2025.101947_bib99","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav5519","article-title":"Brain-resident memory T cells generated early in life predispose to autoimmune disease in mice","volume":"11","author":"Steinbach","year":"2019","journal-title":"Sci. Transl. Med"},{"issue":"640","key":"10.1016\/j.smim.2025.101947_bib100","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abl6157","article-title":"Tissue-resident CD8(+) T cells drive compartmentalized and chronic autoimmune damage against CNS neurons","volume":"14","author":"Frieser","year":"2022","journal-title":"Sci. Transl. Med"},{"issue":"2","key":"10.1016\/j.smim.2025.101947_bib101","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cell.2018.07.049","article-title":"Neurons under T cell attack coordinate phagocyte-mediated synaptic stripping","volume":"175","author":"Di Liberto","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.smim.2025.101947_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.05.031","article-title":"STING orchestrates the neuronal inflammatory stress response in multiple sclerosis","author":"Woo","year":"2024","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.smim.2025.101947_bib103","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41583-024-00823-z","article-title":"The neuropathobiology of multiple sclerosis","volume":"25","author":"Woo","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.smim.2025.101947_bib104","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41467-021-21109-3","article-title":"Persistence of self-reactive CD8+\u2009T cells in the CNS requires TOX-dependent chromatin remodeling","volume":"12","author":"Page","year":"2021","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.smim.2025.101947_bib105","article-title":"Transcription factor c-maf promotes immunoregulation of programmed cell death 1-expressed CD8(+) T cells in multiple sclerosis","volume":"9","author":"Koto","year":"2022","journal-title":"Neurol. (R. ) Neuroimmunol. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.smim.2025.101947_bib106","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"O.I.C. Investigators, ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N. Engl. J. Med"},{"issue":"6","key":"10.1016\/j.smim.2025.101947_bib107","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa1917246","article-title":"A.I.T. groups, ofatumumab versus teriflunomide in multiple sclerosis","volume":"383","author":"Hauser","year":"2020","journal-title":"N. Engl. J. Med"},{"issue":"Pt 4","key":"10.1016\/j.smim.2025.101947_bib108","first-page":"1089","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.smim.2025.101947_bib109","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nm1714","article-title":"Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis","volume":"14","author":"Obermeier","year":"2008","journal-title":"Nat. Med"},{"issue":"3","key":"10.1016\/j.smim.2025.101947_bib110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1352458514522104","article-title":"To look for a needle in a haystack: the search for autoantibodies in multiple sclerosis","volume":"20","author":"Schirmer","year":"2014","journal-title":"Mult. Scler."},{"issue":"28","key":"10.1016\/j.smim.2025.101947_bib111","doi-asserted-by":"crossref","first-page":"7864","DOI":"10.1073\/pnas.1522730113","article-title":"Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins","volume":"113","author":"Brandle","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.smim.2025.101947_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228883","article-title":"Oligoclonal IgG antibodies in multiple sclerosis target patient-specific peptides","volume":"15","author":"Graner","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.smim.2025.101947_bib113","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1084\/jem.20111675","article-title":"B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells","volume":"209","author":"Barr","year":"2012","journal-title":"J. Exp. Med"},{"issue":"12","key":"10.1016\/j.smim.2025.101947_bib114","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41583-019-0233-2","article-title":"B cells in autoimmune and neurodegenerative central nervous system diseases","volume":"20","author":"Sabatino, Jr","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.smim.2025.101947_bib115","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41590-018-0135-x","article-title":"Reassessing B cell contributions in multiple sclerosis","volume":"19","author":"Li","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2025.101947_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155654","article-title":"Role of IL-6 in the commitment of T cell subsets","volume":"146","author":"Korn","year":"2021","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.smim.2025.101947_bib117","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ana.25508","article-title":"Induction of brain-infiltrating T-bet-expressing B cells in multiple sclerosis","volume":"86","author":"van Langelaar","year":"2019","journal-title":"Ann. Neurol."},{"issue":"310","key":"10.1016\/j.smim.2025.101947_bib118","doi-asserted-by":"crossref","first-page":"310ra166","DOI":"10.1126\/scitranslmed.aab4176","article-title":"B.c.i.M.S.T. Canadian, Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy","volume":"7","author":"Li","year":"2015","journal-title":"Sci. Transl. Med"},{"issue":"6","key":"10.1016\/j.smim.2025.101947_bib119","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1093\/brain\/awab025","article-title":"Surface-in pathology in multiple sclerosis: a new view on pathogenesis?","volume":"144","author":"Pardini","year":"2021","journal-title":"Brain"},{"issue":"53","key":"10.1016\/j.smim.2025.101947_bib120","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc7191","article-title":"Gut microbiota-specific IgA(+) B cells traffic to the CNS in active multiple sclerosis","volume":"5","author":"Probstel","year":"2020","journal-title":"Sci. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2025.101947_bib121","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.cell.2018.11.035","article-title":"Recirculating intestinal IgA-producing cells regulate neuroinflammation via IL-10","volume":"176","author":"Rojas","year":"2019","journal-title":"Cell"},{"issue":"6711","key":"10.1016\/j.smim.2025.101947_bib122","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.ade6949","article-title":"Switching off autoimmunity","volume":"385","author":"Laman","year":"2024","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.smim.2025.101947_bib123","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMoa2309439","article-title":"G. Frexalimab phase 2 trial, inhibition of CD40L with frexalimab in multiple sclerosis","volume":"390","author":"Vermersch","year":"2024","journal-title":"N. Engl. J. Med"},{"issue":"9","key":"10.1016\/j.smim.2025.101947_bib124","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S1474-4422(08)70192-3","article-title":"B cells and multiple sclerosis","volume":"7","author":"Franciotta","year":"2008","journal-title":"Lancet Neurol."},{"issue":"Pt 12","key":"10.1016\/j.smim.2025.101947_bib125","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1093\/brain\/awp200","article-title":"Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain","volume":"132","author":"Willis","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.smim.2025.101947_bib126","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally Expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","author":"Lanz","year":"2022","journal-title":"Nature"},{"issue":"104","key":"10.1016\/j.smim.2025.101947_bib127","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adl3604","article-title":"Altered immune landscape of cervical lymph nodes reveals Epstein-Barr virus signature in multiple sclerosis","volume":"10","author":"Sarkkinen","year":"2025","journal-title":"Sci. Immunol."},{"issue":"7909","key":"10.1016\/j.smim.2025.101947_bib128","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","article-title":"TLR7 gain-of-function genetic variation causes human lupus","volume":"605","author":"Brown","year":"2022","journal-title":"Nature"},{"issue":"7639","key":"10.1016\/j.smim.2025.101947_bib129","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.smim.2025.101947_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102300","article-title":"T-bet(high)CD21(low) B cells: the need to unify our understanding of a distinct B cell population in health and disease","volume":"82","author":"Keller","year":"2023","journal-title":"Curr. Opin. Immunol."},{"issue":"12","key":"10.1016\/j.smim.2025.101947_bib131","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41577-022-00718-z","article-title":"The immunology of multiple sclerosis","volume":"22","author":"Attfield","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"8039","key":"10.1016\/j.smim.2025.101947_bib132","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41586-024-08043-2","article-title":"A lymphocyte chemoaffinity axis for lung, non-intestinal mucosae and CNS","volume":"635","author":"Ocon","year":"2024","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.smim.2025.101947_bib133","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.it.2012.07.004","article-title":"Capture, crawl, cross: the T cell code to breach the blood-brain barriers","volume":"33","author":"Engelhardt","year":"2012","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.smim.2025.101947_bib134","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ana.24242","article-title":"The formation of inflammatory demyelinated lesions in cerebral white matter","volume":"76","author":"Maggi","year":"2014","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.smim.2025.101947_bib135","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/s41467-019-08976-7","article-title":"Transcriptional profiling of human microglia reveals grey-white matter heterogeneity and multiple sclerosis-associated changes","volume":"10","author":"van der Poel","year":"2019","journal-title":"Nat. Commun."},{"issue":"6737","key":"10.1016\/j.smim.2025.101947_bib136","doi-asserted-by":"crossref","DOI":"10.1126\/science.adp6325","article-title":"4D marmoset brain map reveals MRI and molecular signatures for onset of multiple sclerosis-like lesions","volume":"387","author":"Lin","year":"2025","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.smim.2025.101947_bib137","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/eji.200737271","article-title":"IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis","volume":"38","author":"Martinez-Forero","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"Pt 5","key":"10.1016\/j.smim.2025.101947_bib138","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/brain\/awp070","article-title":"The relation between inflammation and neurodegeneration in multiple sclerosis brains","volume":"132","author":"Frischer","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.smim.2025.101947_bib139","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.3389\/fimmu.2018.03116","article-title":"Pathogenic mechanisms associated with different clinical courses of multiple sclerosis","volume":"9","author":"Lassmann","year":"2018","journal-title":"Front Immunol."},{"issue":"7796","key":"10.1016\/j.smim.2025.101947_bib140","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-020-1999-0","article-title":"MAFG-driven astrocytes promote CNS inflammation","volume":"578","author":"Wheeler","year":"2020","journal-title":"Nature"},{"issue":"7772","key":"10.1016\/j.smim.2025.101947_bib141","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41586-019-1404-z","article-title":"Neuronal vulnerability and multilineage diversity in multiple sclerosis","volume":"573","author":"Schirmer","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.smim.2025.101947_bib142","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-021-03892-7","article-title":"A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis","author":"Absinta","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.smim.2025.101947_bib143","article-title":"Multiple sclerosis: glial cell diversity in time and space","author":"Kooistra","year":"2024","journal-title":"Glia"},{"key":"10.1016\/j.smim.2025.101947_bib144","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev-immunol-093019-110159","article-title":"Microglia and central nervous system-associated macrophages-from origin to disease modulation","volume":"39","author":"Prinz","year":"2021","journal-title":"Annu Rev. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2025.101947_bib145","article-title":"Resident memory-like CD8(+) T cells are involved in chronic inflammatory and neurodegenerative diseases in the CNS","volume":"11","author":"Kimura","year":"2024","journal-title":"Neurol. (R. ) Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.smim.2025.101947_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102211","article-title":"Tissue-resident CD8 T cells in central nervous system inflammatory diseases: present at the crime scene and guilty","volume":"77","author":"Merkler","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.smim.2025.101947_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578036","article-title":"Tissue-resident memory T cells in the multiple sclerosis brain and their relationship to Epstein-Barr virus infected B cells","volume":"376","author":"Serafini","year":"2023","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.smim.2025.101947_bib148","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/icb.2017.3","article-title":"IL-10-producing, ST2-expressing Foxp3(+) T cells in multiple sclerosis brain lesions","volume":"95","author":"Zandee","year":"2017","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.smim.2025.101947_bib149","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.imlet.2022.06.005","article-title":"Brain-resident regulatory T cells and their role in health and disease","volume":"248","author":"Liston","year":"2022","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.smim.2025.101947_bib150","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1038\/s41467-022-31130-9","article-title":"Selective activation and expansion of regulatory T cells using lipid encapsulated mRNA encoding a long-acting IL-2 mutein","volume":"13","author":"de Picciotto","year":"2022","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.smim.2025.101947_bib151","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.immuni.2015.11.010","article-title":"Integration of Th17- and lymphotoxin-derived signals initiates meningeal-resident stromal cell remodeling to propagate neuroinflammation","volume":"43","author":"Pikor","year":"2015","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.smim.2025.101947_bib152","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/brain\/awab093","article-title":"Formation and immunomodulatory function of meningeal B cell aggregates in progressive CNS autoimmunity","volume":"144","author":"Mitsdoerffer","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.smim.2025.101947_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.607766","article-title":"Ectopic lymphoid follicles in multiple sclerosis: centers for disease control?","volume":"11","author":"Negron","year":"2020","journal-title":"Front Neurol."},{"issue":"3","key":"10.1016\/j.smim.2025.101947_bib154","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/imm.13395","article-title":"Ectopic lymphoid follicles in progressive multiple sclerosis: from patients to animal models","volume":"164","author":"Zhan","year":"2021","journal-title":"Immunology"},{"issue":"Pt 9","key":"10.1016\/j.smim.2025.101947_bib155","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/brain\/awr182","article-title":"Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis","volume":"134","author":"Howell","year":"2011","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.smim.2025.101947_bib156","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ana.25365","article-title":"Meningeal inflammation and cortical demyelination in acute multiple sclerosis","volume":"84","author":"Bevan","year":"2018","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.smim.2025.101947_bib157","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41582-024-01006-1","article-title":"Assessing disease progression and treatment response in progressive multiple sclerosis","volume":"20","author":"Comi","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.smim.2025.101947_bib158","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3389\/fimmu.2016.00451","article-title":"Tertiary lymphoid organs in central nervous system autoimmunity","volume":"7","author":"Mitsdoerffer","year":"2016","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.smim.2025.101947_bib159","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1474-4422(24)00140-6","article-title":"B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseases","volume":"23","author":"Haghikia,","year":"2024","journal-title":"The Lancet Neurology"},{"issue":"7638","key":"10.1016\/j.smim.2025.101947_bib160","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"issue":"8005","key":"10.1016\/j.smim.2025.101947_bib161","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41586-024-07187-5","article-title":"Disease-associated astrocyte epigenetic memory promotes CNS pathology","volume":"627","author":"Lee","year":"2024","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.smim.2025.101947_bib162","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/bpa.12910","article-title":"Deciphering the heterogeneity of myeloid cells during neuroinflammation in the single-cell era","volume":"30","author":"Borst","year":"2020","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.smim.2025.101947_bib163","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-023-02676-9","article-title":"The niche matters: origin, function and fate of CNS-associated macrophages during health and disease","volume":"147","author":"Gasull","year":"2024","journal-title":"Acta Neuropathol."},{"issue":"10","key":"10.1016\/j.smim.2025.101947_bib164","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1073\/pnas.89.10.4588","article-title":"Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions","volume":"89","author":"Wucherpfennig","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.smim.2025.101947_bib165","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/2013.jamaneurol.409","article-title":"Enriched CD161high CCR6+\u2009gammadelta T cells in the cerebrospinal fluid of patients with multiple sclerosis","volume":"70","author":"Schirmer","year":"2013","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.smim.2025.101947_bib166","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1002\/eji.201344160","article-title":"CD8(+) MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis","volume":"44","author":"Willing","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2025.101947_bib167","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4049\/jimmunol.1701213","article-title":"Production of IL-17 by MAIT cells is increased in multiple sclerosis and is associated with IL-7 receptor expression","volume":"200","author":"Willing","year":"2018","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2025.101947_bib168","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.chembiol.2023.09.008","article-title":"Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGs","volume":"31","author":"Pornnoppadol","year":"2024","journal-title":"Cell Chem. Biol."}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532325000193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532325000193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:47:46Z","timestamp":1762354066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532325000193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":168,"alternative-id":["S1044532325000193"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2025.101947","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of the adaptive immune system in the initiation and persistence of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2025.101947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101947"}}